HOME >> BIOLOGY >> NEWS
'PET/CT in Cancer Patient Management' examined in Journal of Nuclear Medicine Supplement

RESTON, Va. -- "PET/CT in Cancer Patient Management" is the subject of a special supplement to the January issue of the Journal of Nuclear Medicine. SNM, the largest molecular imaging and nuclear medicine association, is publishing a unique collection of articles that explores the role of 18F-FDG PET/CT imaging in patient screening, cancer diagnosis, initial treatment planning, treatment monitoring and detection of early recurrence.

"Oncologists, internists, general practitioners, radiologists and nuclear medicine physicians are frequently overwhelmed by the need to select--from among the different imaging modalities--the one that best serves the needs of their patients," notes the supplement's guest editor Johannes Czernin, the director of the Nuclear Medicine Clinic and professor and vice chair of molecular and medical pharmacology at the University of California, Los Angeles. "Despite the impressive growth of PET/CT, there is no consensus on the optimum clinical use of PET/CT and its implementation into patient management," he added, thereby prompting the publication of this exceptional resource.

"Selecting the 'best' PET/CT protocol for a given clinical problem adds another layer of complexity for referring physicians and practicing imaging specialists who need to avoid redundancies in diagnostic tests that frequently involve radiation," said Heinrich Schelbert, who is editor in chief of JNM, the most prominent peer-reviewed journal in nuclear medicine, molecular imaging and allied disciplines.

Doctors use positron emission tomography (PET) and computed tomography (CT) scans as standard imaging tools to pinpoint disease states in the body. When PET is used to image cancer, a radiopharmaceutical (such as fluorodeoxyglucose or FDG, which includes both a sugar and a radionuclide) is injected into a patient. Cancer cells metabolize sugar at higher rates than normal cells, and the radiopharmaceutical is drawn in higher concentrations
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
2-Jan-2007


Page: 1 2 3 4

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. The Cancer Genome Atlas awards funds for technology development
4. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
5. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
6. Cancer stem cells can go it alone
7. Cancer drug enhances long-term memory
8. Cancer cells reprogram energy needs to grow and spread, study suggests
9. Cancer scientists create human leukemia process to map how disease begins, progresses
10. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
11. Other highlights from the April 18 Journal of the National Cancer Institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... 02, 2018 , ... Stem Cell Innovations (SCI), a global network of professionals ... therapy, has launched the pre-sale for their ICO with participants purchasing SCIA ... connect patients and stem cell specialists around the world. , SCI (formally ...
(Date:10/1/2018)... ... October 01, 2018 , ... NanoValent ... (ADC) like, lipid based therapeutics, today announced the National Institute of Health ... award of first year funding for two separate grants. These two grants will ...
(Date:10/1/2018)... Calif. (PRWEB) , ... October ... ... of post-translational modifications (PTMs) presents a unique challenge to proteomic studies. Often, ... within each protein. Although label-free data-independent acquisitions (DIA, or SWATH®Acquisition) have been ...
Breaking Biology News(10 mins):
(Date:10/13/2018)... , ... October 12, 2018 , ... ... society for laser education, innovation and commercialization, celebrates its 50th birthday in New ... Applications of Lasers and Electro-Optics (ICALEO) conference. , In celebration of its ...
(Date:10/5/2018)... ... October 04, 2018 , ... ... along with Duke University, announced today at IDWeek™ 2018 the positive results of ... pathogen DNA in plasma, accurately identified causative pathogens in patients with infective endocarditis ...
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for the 2018 ... AssurEOR product line was chosen for its advancements in the production chemicals category. ... innovations in upstream oil applications that are positively impacting the industry. The winners ...
(Date:9/28/2018)... ... September 28, 2018 , ... LabRoots , the ... scientists from around the world, is excited to announce Daniel Andrade, a 22-year-old ... the winner of the LabRoots Summer 2018 Textbook Scholarship, awarding him $1,000 to ...
Breaking Biology Technology:
Cached News: